Conclusion This RCT provides evidence to show that GlyNAC supplementation in OA improves GSH deficiency, OxS, mitochondrial impairment, mitophagy, inflammation, insulin resistance, endothelial dysfunction, physical function and strength, exercise capacity, waist circumference, state systolic blood pressure, and multiple hallmarks of aging (mitochondrial dysfunction, altered intercellular communication, dysregulated nutrient sensing, loss of proteostasis, genomic toxicity, stem-cell exhaustion, and cellular senescence)
Activation of Sirtuin Pathways (SIRT1) Sirtuins are a family of proteins that regulate metabolism, inflammation, and cellular aging
Factors favouring transdermal absorption are high lipid solubility and a good regional blood supply to the site of application (therefore, the thorax and abdomen are preferred to limbs)
What's changed in 2026 is that the regulatory environment requires more specificity from providers about sourcing and compliance, and gives patients better grounds for distinguishing between clinics that are tracking the regulatory picture and those that aren't
PMCID: PMC6037763
